Dr. Pant on Immunotherapy Combos and Upcoming Developments in Pancreatic Cancer
Shubham Pant, MD, associate medical director of the Clinical & Translational Research Center, associate professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses combination immunotherapies and upcoming developments in pancreatic cancer.
There is a lot of interest in immunotherapy in the field of oncology; however, this has been more of a challenge in pancreatic cancer, says Pant. However, combination immunotherapies, especially agents that target tumor microenvironments and create a less immune suppressive microenvironment, look promising. Read more . . .